Citadel Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50.4M Sell
591,900
-13,300
-2% -$1.19M 0.01% 1349
2025
Q4
$47.8M Buy
605,200
+226,900
+60% +$17.8M 0.01% 1454
2025
Q3
$30.2M Sell
378,300
-56,200
-13% -$4.79M ﹤0.01% 1868
2025
Q2
$39.5M Buy
434,500
+6,900
+2% +$630K 0.01% 1427
2025
Q1
$40.1M Sell
427,600
-160,900
-27% -$14.4M 0.01% 1343
2024
Q4
$53.5M Buy
588,500
+33,100
+6% +$3.16M 0.01% 1213
2024
Q3
$57.7M Sell
555,400
-71,500
-11% -$7.29M 0.01% 1080
2024
Q2
$60.8M Sell
626,900
-959,200
-60% -$88.5M 0.01% 999
2024
Q1
$143M Buy
1,586,100
+5,300
+0.3% +$449K 0.03% 510
2023
Q4
$126M Buy
1,580,800
+1,121,300
+244% +$84.3M 0.03% 561
2023
Q3
$32.7M Sell
459,500
-132,400
-22% -$9.9M 0.01% 1429
2023
Q2
$45.6M Sell
591,900
-9,400
-2% -$728K 0.01% 1123
2023
Q1
$45.2M Sell
601,300
-108,300
-15% -$8.05M 0.01% 1161
2022
Q4
$55.9M Sell
709,600
-130,100
-15% -$9.75M 0.01% 1034
2022
Q3
$59M Buy
839,700
+53,500
+7% +$4.19M 0.01% 935
2022
Q2
$63M Buy
786,200
+119,000
+18% +$9.31M 0.02% 852
2022
Q1
$50.6M Buy
667,200
+212,400
+47% +$16.8M 0.01% 1111
2021
Q4
$38.8M Sell
454,800
-59,300
-12% -$4.63M 0.01% 1376
2021
Q3
$38.9M Buy
514,100
+197,900
+63% +$15.7M 0.01% 1325
2021
Q2
$25.7M Sell
316,200
-132,600
-30% -$10.8M 0.01% 1776
2021
Q1
$35.4M Sell
448,800
-27,600
-6% -$2.16M 0.01% 1367
2020
Q4
$40.7M Buy
476,400
+73,800
+18% +$6.1M 0.01% 1119
2020
Q3
$31.1M Sell
402,600
-387,600
-49% -$29.6M 0.01% 1188
2020
Q2
$57.9M Buy
790,200
+217,000
+38% +$15.4M 0.02% 714
2020
Q1
$38M Buy
573,200
+318,300
+125% +$22.4M 0.02% 782
2019
Q4
$17.5M Sell
254,900
-113,000
-31% -$7.7M 0.01% 1604
2019
Q3
$27M Buy
367,900
+7,000
+2% +$508K 0.01% 1220
2019
Q2
$25.9M Sell
360,900
-115,600
-24% -$8.21M 0.01% 1192
2019
Q1
$32.7M Sell
476,500
-153,900
-24% -$9.94M 0.02% 952
2018
Q4
$37.5M Buy
630,400
+238,300
+61% +$14.9M 0.02% 782
2018
Q3
$26.3M Buy
392,100
+75,600
+24% +$5.04M 0.01% 1179
2018
Q2
$20.5M Sell
316,500
-125,600
-28% -$8.22M 0.01% 1294
2018
Q1
$31.7M Buy
442,100
+282,000
+176% +$20.3M 0.02% 822
2017
Q4
$12.1M Buy
160,100
+15,300
+11% +$1.12M 0.01% 1554
2017
Q3
$10.5M Sell
144,800
-112,800
-44% -$8.13M 0.01% 1560
2017
Q2
$19.1M Buy
257,600
+16,200
+7% +$1.2M 0.02% 1022
2017
Q1
$17.7M Buy
241,400
+125,200
+108% +$8.76M 0.02% 1054
2016
Q4
$7.61M Sell
116,200
-143,800
-55% -$9.86M 0.01% 1596
2016
Q3
$19.3M Buy
260,000
+63,200
+32% +$4.67M 0.02% 891
2016
Q2
$14.4M Sell
196,800
-38,400
-16% -$2.73M 0.02% 988
2016
Q1
$16.6M Buy
235,200
+73,300
+45% +$4.88M 0.02% 859
2015
Q4
$10.8M Sell
161,900
-22,300
-12% -$1.48M 0.01% 1222
2015
Q3
$11.7M Sell
184,200
-62,100
-25% -$4.06M 0.01% 1242
2015
Q2
$16.1M Buy
246,300
+45,800
+23% +$3.11M 0.01% 1153
2015
Q1
$13.9M Buy
200,500
+6,400
+3% +$442K 0.01% 1211
2014
Q4
$13.4M Sell
194,100
-4,700
-2% -$317K 0.01% 1196
2014
Q3
$13M Buy
198,800
+130,200
+190% +$8.59M 0.01% 1198
2014
Q2
$4.68M Sell
68,600
-35,300
-34% -$2.37M 0.01% 1889
2014
Q1
$6.74M Sell
103,900
-4,300
-4% -$271K 0.01% 1534
2013
Q4
$7.06M Sell
108,200
-57,100
-35% -$3.65M 0.01% 1438
2013
Q3
$9.8M Sell
165,300
-59,100
-26% -$3.5M 0.01% 1114
2013
Q2
$12.9M Buy
+224,400
New +$13.3M 0.02% 903

Other funds holding CL

Citadel Advisors's CL Position: Q1 2026 in Review

Citadel Advisors reduced its Colgate-Palmolive (CL) stake by 56% in Q1 2026, selling an estimated $360M and leaving 3,183,995 shares worth $271M. The position accounts for 0.04% of the portfolio, ranked #333.

Citadel Advisors first reported a position in CL in Q2 2013 and has held it in 50 quarters since. The position peaked at $571M in Q4 2025. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Citadel Advisors held 3,183,995 shares of Colgate-Palmolive worth $271M as of Q1 2026.
  • Citadel Advisors sold 4,040,509 Colgate-Palmolive shares in Q1 2026, an estimated $360M.
  • Colgate-Palmolive made up 0.04% of Citadel Advisors's portfolio in Q1 2026, its #333 holding.
  • Citadel Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Colgate-Palmolive position peaked at $571M in Q4 2025.
  • 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.